$142.37 -$0.12 (-0.1%)

04:15 PM EDT on 07/10/20

Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 5 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Current Price $142.37 Mkt Cap $375.1B
Open $142.75 P/E Ratio 21.88
Prev. Close $142.37 Div. (Yield) $3.86 (2.7%)
Daily Range $141.45 - $142.85 Volume 1,335,426
52-Wk Range $109.16 - $157.00 Avg. Daily Vol. 7,305,427

Caps

How do you think NYSE:JNJ will perform against the market?

Add Stock to CAPS Watchlist

All Players

13,608 Outperform
506 Underperform
 

All-Star Players

2,701 Outperform
60 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:JNJ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFbelle (60.92)
Submitted July 02, 2014

A stock which I feel should be a staple in every dividend/value investor portfolio. The quality of this company has stood the test of time and they continue to remain relevant and successful via strategies that strengthen it's ongoing competitive… More

acegdl007 (81.36)
Submitted January 20, 2011

J&J is not a company that has experienced significant growth (in terms of stock price) over the past few years. It has mainly sustained its self on it's brand name recognition that has been significantly tarnished in 2010 due to several recalls.… More

Recent Community Commentary

Read the most recent pitches from players about JNJ.

Recs

0
Member Avatar whitetorch (< 20) Submitted: 6/17/2020 2:48:36 PM : Outperform Start Price: $144.93 NYSE:JNJ Score: -3.10

If "sexy" is your criteria it's clearly time to move along; but if you asked me to name a proven winner over multiple past decades this would very likely be the first name that came to mind...by a wide margin. J&J is well-positioned in three important spaces that are all favorites to become even more so times change. They grow, and they provide a reasonable dividend, having increased the latter for 56 years. That's not merely "dividend aristocrat" status but "dividend king."

Recs

0
Member Avatar Gatsby32 (< 20) Submitted: 5/23/2020 9:19:52 PM : Outperform Start Price: $145.94 NYSE:JNJ Score: -6.85

Will get GREAT review on covid-19 drug test.

Recs

0
Member Avatar terig965 (56.15) Submitted: 4/14/2020 12:26:37 PM : Outperform Start Price: $145.36 NYSE:JNJ Score: -14.48

they are a healthcare giant

Leaderboard

Find the members with the highest scoring picks in JNJ.

Score Leader

PassDaRice2

PassDaRice2 (83.39) Score: +133.07

The Score Leader is the player with the highest score across all their picks in JNJ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tarfu773 88.34 7/30/2007 Outperform 5Y $40.76 +249.26% +126.74% +122.53 1 Comment
UWxBadger 87.83 7/30/2007 Outperform 5Y $40.78 +249.08% +126.57% +122.52 0 Comment
diediedieno 41.70 7/27/2007 Outperform 5Y $40.79 +249.03% +126.51% +122.52 0 Comment
bullear1 65.28 7/24/2007 Outperform 3Y $41.77 +240.87% +118.49% +122.37 0 Comment
jbarnes1217 90.77 7/24/2007 Outperform 3Y $41.77 +240.87% +118.49% +122.37 0 Comment
paladin65 < 20 7/24/2007 Outperform 1Y $41.77 +240.87% +118.49% +122.37 1 Comment
cando123 26.46 7/24/2007 Outperform 5Y $41.77 +240.87% +118.49% +122.37 0 Comment
GreedyMo 95.13 7/24/2007 9/30/2012 Outperform 5Y $41.77 +240.87% +118.49% +122.37 0 Comment
fartalope < 20 7/24/2007 Outperform 5Y $41.77 +240.87% +118.49% +122.37 1 Comment
kaibigan < 20 7/24/2007 Outperform NS $41.77 +240.87% +118.49% +122.37 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for JNJ.